Literature DB >> 27986564

Inhibition of Japanese encephalitis virus (JEV) replication by specific RNA aptamer against JEV methyltransferase.

Seung Ryul Han1, Seong-Wook Lee2.   

Abstract

Japanese encephalitis virus (JEV) is the most common etiological agent of epidemic viral encephalitis. JEV encodes a single methyltransferase (MTase) domain located at the N-terminal region of the viral nonstructural protein NS5. JEV MTase is essential for viral replication and specifically catalyzes methylation of the viral RNA cap, which occurs exclusively in the cytoplasm. Therefore, JEV MTase is a potential target for antiviral therapy. Here, we identified specific and avid RNA aptamer (Kd ∼ 12 nM) with modified 2'-O-methyl pyrimidines against JEV MTase. The RNA aptamer efficiently inhibited viral cap methylation activity of MTase and interfered with JEV production in cells. Moreover, we generated a 24-mer truncated aptamer that could specifically bind to JEV MTase with high affinity (Kd ∼16 nM). The 24-mer aptamer efficiently inhibited JEV production and replication in cells. Therefore, MTase-specific RNA aptamer might be useful as an anti-JEV agent.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Anti-viral agent; Japanese encephalitis virus; Methyltransferase; RNA aptamer

Mesh:

Substances:

Year:  2016        PMID: 27986564     DOI: 10.1016/j.bbrc.2016.12.081

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

Review 1.  Aptamers isolated against mosquito-borne pathogens.

Authors:  Tholasi Nadhan Navien; Tzi Shien Yeoh; Andrew Anna; Thean-Hock Tang; Marimuthu Citartan
Journal:  World J Microbiol Biotechnol       Date:  2021-07-09       Impact factor: 3.312

Review 2.  RNA regulatory processes in RNA virus biology.

Authors:  Shaun T Cross; Daniel Michalski; Megan R Miller; Jeffrey Wilusz
Journal:  Wiley Interdiscip Rev RNA       Date:  2019-04-29       Impact factor: 9.957

Review 3.  Application of Aptamers in Virus Detection and Antiviral Therapy.

Authors:  Xinran Zou; Jing Wu; Jiaqi Gu; Li Shen; Lingxiang Mao
Journal:  Front Microbiol       Date:  2019-07-03       Impact factor: 5.640

Review 4.  Biochemical features and mutations of key proteins in SARS-CoV-2 and their impacts on RNA therapeutics.

Authors:  Li Zeng; Dongying Li; Weida Tong; Tieliu Shi; Baitang Ning
Journal:  Biochem Pharmacol       Date:  2021-01-19       Impact factor: 5.858

Review 5.  Aptamers for Anti-Viral Therapeutics and Diagnostics.

Authors:  Tae-Hyeong Kim; Seong-Wook Lee
Journal:  Int J Mol Sci       Date:  2021-04-17       Impact factor: 5.923

6.  Chemical biology and medicinal chemistry of RNA methyltransferases.

Authors:  Tim R Fischer; Laurenz Meidner; Marvin Schwickert; Marlies Weber; Robert A Zimmermann; Christian Kersten; Tanja Schirmeister; Mark Helm
Journal:  Nucleic Acids Res       Date:  2022-05-06       Impact factor: 19.160

Review 7.  Aptamers targeting SARS-COV-2: a promising tool to fight against COVID-19.

Authors:  Yang Zhang; Mario Juhas; Chun Kit Kwok
Journal:  Trends Biotechnol       Date:  2022-08-01       Impact factor: 21.942

8.  Generation and characterization of Japanese encephalitis virus expressing GFP reporter gene for high throughput drug screening.

Authors:  Zhe-Rui Zhang; Hong-Qing Zhang; Xiao-Dan Li; Cheng-Lin Deng; Zhen Wang; Jia-Qi Li; Na Li; Qiu-Yan Zhang; Hong-Lei Zhang; Bo Zhang; Han-Qing Ye
Journal:  Antiviral Res       Date:  2020-08-01       Impact factor: 5.970

Review 9.  Aptamer Applications in Emerging Viral Diseases.

Authors:  Arne Krüger; Ana Paula de Jesus Santos; Vanessa de Sá; Henning Ulrich; Carsten Wrenger
Journal:  Pharmaceuticals (Basel)       Date:  2021-06-28

Review 10.  Oligonucleotide aptamers for pathogen detection and infectious disease control.

Authors:  Quanyuan Wan; Xiaohui Liu; Youli Zu
Journal:  Theranostics       Date:  2021-08-27       Impact factor: 11.556

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.